Lorem ipsum dolor sit amet In optio atque rem, quis similique ducimus hic cum eum
Lorem, ipsum dolor sit amet consectetur adipisicing elit. In optio atque rem, quis similique ducimus hic cum eum fugiat beatae dignissimos magni nihil libero blanditiis sapiente sint deleniti at illum!
One-size does not fit all across today's diverse and dynamic test settings. From antigen to molecular tests and various use cases, rapid test methods offer unique and overlapping utility, advantages, and disadvantages.
Expert perspectives on rapid point-of-care testing for respiratory infections
This updated guidance from the Infectious Diseases Society of America (IDSA) covers diagnosis,
treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza.
IDSA clinical practice guideline update on the management of seasonal influenza
Following 19 months of consultation, this report sets out the Review on Antimicrobial Resistance’s final recommendations to tackle antimicrobial resistance (AMR) globally, as commissioned by sponsors, the UK Government and the Wellcome Trust.
Tackling drug-resistant infections globally: report and recommendations
Join this interactive discussion on how the different adoption of C-reactive protein point-of-care testing in different countries has influenced and could influence antibiotic misuse and antimicrobial resistance rates.
Fighting forwards: how to keep antibiotics working in an age of resistance
In our feature article series, we take a look at publications of particular relevance to point-of-care testing (POCT), providing summaries and expert commentary on the key aspects of the paper and within the wider context of POCT systems.In this article, we cover the below publication by Professor Cooke and co-authors
Respiratory tract infections in primary care: narrative review of CRP point-of-care testing and antibacterial use
The views and opinions presented are of the author only. The content contained in this podcast is intended for informational / educational purposes only.
Point-of-care testing for reducing risk and improving management of infectious diseases
The 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) will bring together more than 14,000 attendees from all over the world, plus experts from relevant fields to present the latest findings and share their expertise.
European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Health Information and Quality Authority (HIQA), published online April 2019This health technology assessment (HTA) aimed to establish the clinical and cost-effectiveness of CRP POCT, plus examined the organisational implications of the potential introduction of the technology into primary care. A summary of key findings is provided below:
Health Technology Assessment of CRP POCT to guide antibiotic prescribing for acute respiratory tract infections in primary care settings
European Network for Health Technology Assessment (EUnetHTA), published online January 2019This collaborative assessment on C-reactive protein (CRP) point-of-care testing (POCT) aims to guide antibiotic prescribing in primary care settings for acute respiratory tract infections (RTIs). The assessment sought to answer three questions by conducting three separate systematic reviews:
C-reactive protein POCT to guide antibiotic prescribing in primary care settings for acute respiratory tract infections
Jan Verbakel, Joseph Lee, Clare Goyder, Pui San Tan, Thanusha Ananthakumar, Philip Turner, Gail Hayward, and Ann Van den BruelBMJ Open, 2019The aim of this review was to collate all available evidence on the impact of C-reactive protein (CRP) point-of-care testing (POCT) on patient-relevant outcomes in children and adults in ambulatory care.
Impact of CRP POC testing in ambulatory care: a systematic review and meta-analysis
The World Anti-Microbial Resistance (AMR) congress is the world’s largest AMR congress, with approximately 800 attendees from across approximately 50 countries and more than 250 speakers.
The World Anti-Microbial Resistance (AMR) congress is the world’s largest AMR congress, with ~800 attendees from across ~50 countries and more than 250 speakers. This year, on 8–9 October 2020, myPOCacademy hosted a live seminar led by Professor Jonathan Cooke from Imperial College London and the University of Manchester (UK), now exclusively available to watch in full here.
Hear how point-of-care testing may aid in reducing antimicrobial resistance during the COVID-19 pandemic
The ERS international congress on 7–9 September 2020 delivered the latest innovations in respiratory medicine, plus offered an opportunity to interact and connect with the respiratory community virtually.
European Respiratory Society virtual international congress 2020
Check out the on-demand symposium recording from the European Respiratory Society congress 2020 by clicking here. Learn how C-reactive protein (CRP) point-of-care testing can be a valuable diagnostic and clinical decision-making tool in relation to COVID-19, and how it may also inform antibiotic prescribing for acutely exacerbated chronic obstructive pulmonary disease (COPD) patients.
Learn about the value of CRP point-of-care testing for COPD and antimicrobial resistance in the context of COVID-19
An international expert panel discusses POCT related to COVID-19 severity assessment and risk prediction, plus covers the role of POCT in antimicrobial resistance during the pandemic, in this video seminar originally delivered live on 9 September 2020. Hear from Professor Nicholas Francis (UK), Professor Ivan Gentile (Italy), Dr Carl Llor (Spain), Professor Dag Berild (Norway) and Dr Aggy York (UK) by clicking here.
Hear expert opinion on the use of CRP point-of-care testing for COVID-19 management and reduction of antimicrobial resistance
en
Access Now
Certified Content
No More Results
By using this site, you agree with our use of cookies.
